Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats
- PMID: 12681531
- DOI: 10.1016/s0376-8716(02)00333-2
Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats
Abstract
Alcohol deprivation effect (ADE), i.e. the transient increase in alcohol intake that takes place in laboratory animals after a period of alcohol deprivation, has been proposed to model alcohol relapses in alcoholics. The present study investigated the effect of the GABA(B) receptor agonist, baclofen, on the development of ADE in selectively bred Sardinian alcohol-preferring (sP) rats. Acute administration of non-sedative doses of baclofen (0, 1, 1.7 and 3 mg/kg, i.p.) resulted in the complete suppression of the extra-amount of alcohol consumed during the first hour of re-access to alcohol after 7 days of deprivation. These results implicate the GABA(B) receptor in the neural substrate mediating ADE and suggest that baclofen may possess anti-relapse properties.
Similar articles
-
Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.Neurotox Res. 2004;6(5):403-14. doi: 10.1007/BF03033315. Neurotox Res. 2004. PMID: 15545024 Review.
-
Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations.Eur J Pharmacol. 2006 Nov 21;550(1-3):123-6. doi: 10.1016/j.ejphar.2006.08.052. Epub 2006 Sep 8. Eur J Pharmacol. 2006. PMID: 17022968
-
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.Alcohol Clin Exp Res. 2000 Jan;24(1):67-71. Alcohol Clin Exp Res. 2000. PMID: 10656195
-
Development of an alcohol deprivation and escalation effect in C57BL/6J mice.Alcohol Clin Exp Res. 2006 Dec;30(12):2017-25. doi: 10.1111/j.1530-0277.2006.00248.x. Alcohol Clin Exp Res. 2006. PMID: 17117967
-
Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.Curr Pharm Des. 2010;16(19):2113-7. doi: 10.2174/138161210791516440. Curr Pharm Des. 2010. PMID: 20482507 Review.
Cited by
-
Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.CNS Drugs. 2019 Feb;33(2):107-123. doi: 10.1007/s40263-018-0596-3. CNS Drugs. 2019. PMID: 30604283 Review.
-
Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.Neurotox Res. 2004;6(5):403-14. doi: 10.1007/BF03033315. Neurotox Res. 2004. PMID: 15545024 Review.
-
Clinical potential of GABAB receptor modulators.CNS Drug Rev. 2005 Autumn;11(3):317-34. doi: 10.1111/j.1527-3458.2005.tb00049.x. CNS Drug Rev. 2005. PMID: 16389296 Free PMC article. Review.
-
Individual differences in social play behaviour predict alcohol intake and control over alcohol seeking in rats.Psychopharmacology (Berl). 2021 Nov;238(11):3119-3130. doi: 10.1007/s00213-021-05929-1. Epub 2021 Aug 2. Psychopharmacology (Berl). 2021. PMID: 34338827 Free PMC article.
-
Baclofen reduces fat intake under binge-type conditions.Physiol Behav. 2005 Sep 15;86(1-2):176-84. doi: 10.1016/j.physbeh.2005.07.020. Physiol Behav. 2005. PMID: 16140347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical